New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Bristol-Myers Squibb Company PFD CONV 2
BMYMP
Shape
US Flag

PNK

Unprofitable

Unprofitable

120B

Drug Manufacturers - General

Next Earning date - 24 Apr 2025

120B

Drug Manufacturers - General

Next Earning date - 24 Apr 2025

1040.41USD

0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

0%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

15%

Quote Panel

Shape
Updated March 16, 2025
1W 0.00 % 1M 15.53 % 3M 11.74 % 1Y 17.18 %

Key Metrics

Shape
  • Market Cap

    119.75B


  • Shares Outstanding

    115.10M


  • Share in Float

    115.01M


  • Dividende

    0.5


  • Earning Date

    24 Apr 2025


  • Price Target

    1040.41


  • Average Volume

    1


  • Beta

    0.19707522


  • Range

    701-1225


  • Industry

    Drug Manufacturers - General


  • Website


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

BMYMP

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Credit Suisse

initialise

Previous: Not converted

2022-11-18

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+4%

15.07
vs 14.5

Q4.22

arrow
arrow

-34%

14.65
vs 22.25

Q1.23

arrow
arrow

+37%

16.47
vs 11.99

Q2.23

arrow
arrow

+14%

15.17
vs 13.33

Q3.23

arrow
arrow

-5%

14.37
vs 15.07

Q4.23

arrow
arrow

-9%

13.33
vs 14.65

Q1.24

arrow
arrow

N/A

-90.58
vs 16.47

Q2.24

arrow
arrow

-16%

12.74
vs 15.17

Q3.24

arrow
arrow

-36%

9.17
vs 14.37

Q4.24

arrow
arrow

-96%

0.55
vs 13.33

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-3%

11.2B  vs 11.6B

Q4.22

arrow
arrow

-5%

11.4B  vs 12B

Q1.23

arrow
arrow

-3%

11.3B  vs 11.6B

Q2.23

arrow
arrow

-6%

11.2B  vs 11.9B

Q3.23

arrow
arrow

-2%

11B  vs 11.2B

Q4.23

arrow
arrow

+1%

11.5B  vs 11.4B

Q1.24

arrow
arrow

+5%

11.9B  vs 11.3B

Q2.24

arrow
arrow

+9%

12.2B  vs 11.2B

Q3.24

arrow
arrow

+8%

11.9B  vs 11B

Q4.24

arrow
arrow

+8%

12.3B  vs 11.5B

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+7%

0.07
vs 0.07

Q2.23

arrow
arrow

+6%

0.06
vs 0.07

Q3.23

arrow
arrow

+7%

0.07
vs 0.06

Q4.23

arrow
arrow

+6%

0.06
vs 0.07

Q1.24

arrow
arrow

-72%

-0.72
vs 0.06

Q2.24

arrow
arrow

+10%

0.1
vs -0.72

Q3.24

arrow
arrow

+7%

0.07
vs 0.1

Q4.24

arrow
arrow

+0%

0
vs 0.07

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News